Investors Alert: Extreme Networks Inc. (NASDAQ:EXTR), The Dow Chemical Company (NYSE:DOW), PhotoMedex, Inc. (NASDAQ:PHMD), CytRx Corporation (NASDAQ:CYTR), Allied Nevada Gold Corp. (NYSEMKT:ANV)

Extreme Networks Inc. (NASDAQ:EXTR) on Tuesday reported a loss of $19.3 million in its fiscal first quarter. The San Jose, California-based company said it had a loss of 20 cents per share. Losses, adjusted for amortization costs and stock option expense, came to 1 cent per share. Extreme Networks Inc. (NASDAQ:EXTR) in last trading activity moved up 10.00% to close at $3.63. Company weekly performance … Continue reading Investors Alert: Extreme Networks Inc. (NASDAQ:EXTR), The Dow Chemical Company (NYSE:DOW), PhotoMedex, Inc. (NASDAQ:PHMD), CytRx Corporation (NASDAQ:CYTR), Allied Nevada Gold Corp. (NYSEMKT:ANV)

Mark DeFrance10/3010/30

Investors Watch List : Merck & Co (NYSE:MRK), Activision Blizzard (NASDAQ:ATVI), Brooks Automation (NASDAQ:BRKS), Entergy Corporation (NYSE:ETR), CytRx Corporation (NASDAQ:CYTR)

Merck & Co. Inc. (NYSE:MRK) has been sued by Bristol-Myers Squibb Co (BMY) and Ono Pharmaceutical Co., Ltd. (Japan) (OPHLY) for patent infringement of Bristol-Myers’ novel PD-1 inhibitor, Optivo. Merck recently won the US Food and Drug Administration’s (FDA) approval for its own PD-1 drug, Keytruda. This made the company the first one to enter the US immunotherapy market, which is expected to reach $35 … Continue reading Investors Watch List : Merck & Co (NYSE:MRK), Activision Blizzard (NASDAQ:ATVI), Brooks Automation (NASDAQ:BRKS), Entergy Corporation (NYSE:ETR), CytRx Corporation (NASDAQ:CYTR)

Chris Lewis09/1109/11

Today’s Hot List : CytRx Corporation (NASDAQ:CYTR), LipoScience, Inc. (NASDAQ:LPDX), India Fund, Inc. (NYSE:IFN), FreeSeas Inc. (NASDAQ:FREE), Enventis Corporation (NASDAQ:ENVE)

CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced a change in the Company’s presentation time at the at Aegis 2014 Healthcare & Technology Conference. President and CEO Steven A. Kriegsman and Vice President of Business Development David Haen will present on Friday, September 12th at 10:45am Pacific Time. CytRx Corporation (NASDAQ:CYTR) belongs to Healthcare sector. weekly performance is 5.72%. On … Continue reading Today’s Hot List : CytRx Corporation (NASDAQ:CYTR), LipoScience, Inc. (NASDAQ:LPDX), India Fund, Inc. (NYSE:IFN), FreeSeas Inc. (NASDAQ:FREE), Enventis Corporation (NASDAQ:ENVE)

Mark DeFrance09/0909/09

Today’s Stocks : CytRx Corporation (NASDAQ:CYTR), Advanced Micro Devices, (NYSE:AMD), First Community Bancshares, Inc. (NASDAQ:FCBC), Altra Industrial Motion Corp. (NASDAQ:AIMC), Excel (NYSE:EXL)

CytRx Corporation (NASDAQ: CYTR) a biopharmaceutical research and development company specializing in oncology today announced a change in the Company’s presentation time at the at Aegis 2014 Healthcare & Technology Conference. President and CEO Steven A. Kriegsman and Vice President of Business Development David Haen will present on Friday September 12th at 10:45am Pacific Time. CytRx Corporation (NASDAQ:CYTR) belongs to Healthcare sector. Its weekly performance … Continue reading Today’s Stocks : CytRx Corporation (NASDAQ:CYTR), Advanced Micro Devices, (NYSE:AMD), First Community Bancshares, Inc. (NASDAQ:FCBC), Altra Industrial Motion Corp. (NASDAQ:AIMC), Excel (NYSE:EXL)

Chris Lewis09/0809/08

Trader’s Watch List – Bed Bath (NASDAQ:BBBY) , Walt Disney (NYSE:DIS) , Rexnord (NYSE:RXN) , CytRx (NASDAQ:CYTR) , Eldorado Gold (NYSE:EGO)

Analysts at Nomura started coverage on shares of Bed Bath & Beyond (NASDAQ:BBBY) in a research report issued to clients and investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating and a $65.00 price target on the stock. Nomura’s target price would indicate a potential upside of 6.56% from the company’s current price. Bed Bath & Beyond Inc. (NASDAQ:BBBY) stock performance was 0.08% … Continue reading Trader’s Watch List – Bed Bath (NASDAQ:BBBY) , Walt Disney (NYSE:DIS) , Rexnord (NYSE:RXN) , CytRx (NASDAQ:CYTR) , Eldorado Gold (NYSE:EGO)

Kevin Long07/2307/23

Healthcare Losers: CytRx (NASDAQ:CYTR), Trivascular Technologies (NASDAQ:TRIV), Neuralstem (NYSEMKT:CUR), Ventrus Biosciences Inc (NASDAQ:VTUS)

The company on May 28 announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas (STS). CytRx Corporation (NASDAQ:CYTR) stock performance was -5.41% in last session and finished the day at $4.02. Traded volume was 9.62million shares … Continue reading Healthcare Losers: CytRx (NASDAQ:CYTR), Trivascular Technologies (NASDAQ:TRIV), Neuralstem (NYSEMKT:CUR), Ventrus Biosciences Inc (NASDAQ:VTUS)

Kristen Barton06/3006/30